İnterferon Gamma 100 Mcg / 0,5 ML

Description

İnterferon Gamma 100 Mcg / 0,5 ML

1.1 Therapeutic indications

Interferon Gamma is indicated for reducing the frequency of serious infections in patients with chronic granulomatous disease (CGD).
Interferon Gamma is indicated for a decrease in the frequency of serious infections in patients with severe malignant osteopetrosis.

1.2 Posology and method of administration
Drug amounts information
The recommended dosage of Interferon Gamma for the treatment of patients with CGD or severe malignant osteopetrosis, the surface area is equal to 0.5 m 2 for patients with a body surface area greater than 50 mcg / m 2, and the surface area for patients with a body size equal to 0.5 m Is 2 or less. In fact, the volume drawn should be checked before injection. Injections should be given subcutaneously, preferably three times a week in the evening (for example, Monday, Wednesday, Friday). Optimum injection sites are right and left deltoid and anterior thigh. Interferon Gamma can be administered by a doctor, nurse, family member or patient when trained in the administration of subcutaneous injections.
Although the most useful Interferon Gamma dose is unknown, higher doses are not recommended. Its safety and efficacy have not been proven for Interferon Gamma given at doses greater or less than the recommended dose of 50 mcg / m 2. If severe reactions occur, the dosage should be modified (50% reduction) or treatment should be stopped until the adverse reaction decreases.
Pediatric population
Experience in children is limited
Method of Application
Interferon Gamma is for subcutaneous use.